Women's Health MRI

Catch up on the most-well viewed radiology content in September 2025.

The AI-powered Tempus Pixel software update provides T1 and T2 inline maps to augment cardiac MRI assessment.

For HER2-positive breast cancer patients with radiologic complete response on breast MRI after neoadjuvant chemotherapy (NAC), the absence of calcifications was associated with over a 13 percent higher positive predictive value (PPV) for pathologic complete response (pCR).

Circumferential aneurysm wall enhancement on MRI was associated with a 3.8-fold higher risk of intracranial aneurysm instability within a four-year period, according to a study involving over 1,350 patients.

For myocardial extracellular volume quantification, single-phase and dual-phase photon-counting CT provided over 20 percent higher correlation with cardiac MRI in contrast to dual-phase energy-integrating detector CT, according to new research findings.

In a 10-study meta-analysis examining the use of whole-body MRI for asymptomatic individuals, researchers noted a pooled cancer detection rate of 1.57 percent.

Catch up on the most-well viewed radiology content in August 2025.

Catch up on the top radiology content of the past week.

Catch up on the top radiology content of the past week.

Incorporating technology from Siemens Healthineers’ Magnetom Skyra Fit system, the Invision 3T Recharge Operating Suite offers AI-powrred protocols and automated image reconstruction capabilities.

In addition to facilitating centralized scanning for a variety of imaging, the TechLive system may help ease the strain of technologist shortages and broaden access to advanced imaging exams.

Lower proportions of extremely dense breasts and high BRCAT lifetime risk among Black women in comparison to White women may have resulted in a lower likelihood of eligibility for supplemental screening insurance coverage in Pennsylvania, according to new research.

The multimodality remote scanning modality uOmniscan and the recently FDA-cleared 3T uMR Ultra MRI system were unveiled at the Association for Medical Imaging Management (AHRA) conference in Las Vegas.

Catch up on the top radiology content of the past week.

The addition of two new AI-enabled models for the latest version of the NeuroQuant Brain Tumor software facilitates automated tracking of the progression of brain tumors and meningiomas.

Catch up on the most-well viewed radiology content in July 2025.

Catch up on the top AI-related news and research in radiology over the past month.

Catch up on the top radiology content of the past week.

Beyond the hype, whole-body MRI offers limited clinical benefit in the general population with extraneous use potentially triggering a cycle of overdiagnosis, unnecessary treatment and financial strain.

In a prospective study involving nearly 100 patients with Long Covid, 57 percent of patients had PET/MRI abnormalities and 90 percent of the cohort had abnormalities on dual-energy CT scans.

Catch up on the latest MRI studies, AI innovations, and expert insights on abbreviated breast MRI with our Weekly Scan.

Noting a 7.4 percent incidence of motion artifacts on brain MRI scans for suspected stroke patients, the authors of a new study found that motion artifacts can reduce radiologist and AI accuracy for detecting hemorrhagic lesions.

In external validation findings from a 29-study meta-analysis, MRI-based AI had a pooled AUC of 85 percent for preoperative prediction for microvascular invasion in patients with hepatocellular carcinoma.

A fully convolutional data description (FCDD) model for identifying anomalies on breast MRI demonstrated an 84 percent AUC for detection tasks in a balanced cohort with a 20 percent malignancy prevalence and a 72 percent AUC for detection tasks in an imbalanced group with a 1.85 percent cancer prevalence.

The updated capabilities of SwiftMR include personalized scan settings within the software, artifact reduction and cloud integration.

For patients with unresectable hepatocellular carcinoma, a pre-treatment MRI finding of LI-RADS tumor in vein was associated with over an 86 percent lower likelihood of responding to transcatheter arterial chemoembolization (TACE) and targeted immunotherapy.

Stay updated with the latest in radiology, including PET, MRI, and AI research, plus essential insights on mammography and cardiac imaging.

For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.

Findings from the TRAILBLAZER-ALZ 6 study revealed a 41 percent reduction of the ARIA-E side effect at 24 weeks with the new dosing schedule for the anti-amyloid treatment donanemab-azbt.

Catch up on the top radiology content of the past week.